Overexpression of Dyrk1A regulates cardiac troponin T splicing in cells and mice.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2016-05-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2016.04.004PMID 27049307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion*

  2012cited by this paper
• Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A.

  2012cited by this paper
• Genetic analysis of Down syndrome-associated heart defects in mice

  2011cited by this paper
• Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A

  2011cited by this paper
• DYRK1A Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy*

  2009cited by this paper
• Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project

  2008cited by this paper
• Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome*♦

  2008cited by this paper
• ASF/SF2-Regulated CaMKII Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac Muscle

  2005cited by this paper
• Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

  2004cited by this paper
• Cardiac troponin T isoforms affect the Ca(2+) sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart.

  2004cited by this paper
• Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.

  2004cited by this paper
• Cardiac Troponin T Isoforms Affect the Ca2+Sensitivity and Inhibition of Force Development

  2002cited by this paper
• Cardiac Troponin T Variants Produced by Aberrant Splicing of Multiple Exons in Animals with High Instances of Dilated Cardiomyopathy*

  2002cited by this paper
• A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy.

  2002cited by this paper
• Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.

  2002cited by this paper
• Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy

  2001cited by this paper
• Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease

  2001cited by this paper
• High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development.

  1999cited by this paper
• Population-based study of congenital heart defects in Down syndrome.

  1998cited by this paper
• Anomalies in Down syndrome individuals in a large population-based registry.

  1998cited by this paper
• Study of Down syndrome in 238,942 consecutive births.

  1998cited by this paper
• Alternative RNA splicing-generated cardiac troponin T isoform switching: a non-heart-restricted genetic programming synchronized in developing cardiac and skeletal muscles.

  1996cited by this paper
• Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart.

  1995cited by this paper
• A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer

  1995cited by this paper
• Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene.

  1985cited by this paper
• A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing.

  1985cited by this paper

• Development and disease-specific regulation of RNA splicing in cardiovascular system

  2024cites this paper
• Function and Inhibition of DYRK1A: emerging roles of treating multiple human diseases.

  2023cites this paper
• Impact of DYRK1A Expression on TNNT2 Splicing and Daunorubicin Toxicity in Human iPSC-Derived Cardiomyocytes

  2022influential citation
• New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease

  2022cites this paper
• A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.

  2022cites this paper
• Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond

  2021cites this paper
• Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors.

  2021cites this paper
• Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome.

  2019cites this paper
• mRNA Metabolism in Cardiac Development and Disease: Life After Transcription

  2019cites this paper
• Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A.

  2016cites this paper